Posted On: 10/02/2013 3:18:42 PM
Post# of 99131
$NVLX had 2 huge news announcements this week! Nice volume today >>>
Yesterday's news: Nuvilex, Inc. Enters Most Important Step of Phase III Trials Outside of Patient Enrollment
http://finance.yahoo.com/news/nuvilex-inc-ent...00450.html
Today's news: Upcoming Q4 Events Bode Well for Nuvilex Shareholders
http://finance.yahoo.com/news/upcoming-q4-eve...00893.html
About Nuvilex, Inc. (OTCQB: NVLX): Nuvilex, Inc. is an international biotechnology firm focused on developing and preparing to commercialize treatments for cancer, diabetes and other diseases based on the live, therapeutically valuable, encapsulated cells platform. The Company is leveraging its cancer biology and clinical oncology research experience and expertise, particularly for use in oncology treatments, in addition to initiating oncology applications of medical marijuana. For more information visit: www.nuvilex.com .
Yesterday's news: Nuvilex, Inc. Enters Most Important Step of Phase III Trials Outside of Patient Enrollment
http://finance.yahoo.com/news/nuvilex-inc-ent...00450.html
Today's news: Upcoming Q4 Events Bode Well for Nuvilex Shareholders
http://finance.yahoo.com/news/upcoming-q4-eve...00893.html
About Nuvilex, Inc. (OTCQB: NVLX): Nuvilex, Inc. is an international biotechnology firm focused on developing and preparing to commercialize treatments for cancer, diabetes and other diseases based on the live, therapeutically valuable, encapsulated cells platform. The Company is leveraging its cancer biology and clinical oncology research experience and expertise, particularly for use in oncology treatments, in addition to initiating oncology applications of medical marijuana. For more information visit: www.nuvilex.com .
(0)
(0)
